Author Correction: Functionally selective signaling and broad metabolic benefits by novel insulin receptor partial agonists

• Margaret Wu,
• Ester Carballo-Jane,
• Haihong Zhou,
• Peter Zafian,
• Ge Dai,
• Mindy Liu,
• Julie Lao,
• Terri Kelly,
• Dan Shao,
• Judith Gorski,
• Dmitri Pissarnitski,
• Ahmet Kekec,
• Ying Chen,
• Stephen F. Previs,
• Giovanna Scapin,
• Yacob Gomez-Llorente,
• Scott A. Hollingsworth,
• Lin Yan,
• Danqing Feng,
• Pei Huo,
• Geoffrey Walford,
• Mark D. Erion,
• David E. Kelley,
• Songnian Lin,
• James Mu

Affiliations

Margaret Wu

Merck & Co., Inc.

Ester Carballo-Jane

Merck & Co., Inc.

Haihong Zhou

Merck & Co., Inc.

Peter Zafian

Merck & Co., Inc.

Ge Dai

Merck & Co., Inc.

Mindy Liu

Merck & Co., Inc.

Julie Lao

Merck & Co., Inc.

Terri Kelly

Merck & Co., Inc.

Dan Shao

Merck & Co., Inc.

Judith Gorski

Merck & Co., Inc.

Dmitri Pissarnitski

Merck & Co., Inc.

Ahmet Kekec

Merck & Co., Inc.

Ying Chen

Merck & Co., Inc.

Stephen F. Previs

Merck & Co., Inc.

Giovanna Scapin

Merck & Co., Inc.

Yacob Gomez-Llorente

Merck & Co., Inc.

Scott A. Hollingsworth

Merck & Co., Inc.

Lin Yan

Merck & Co., Inc.

Danqing Feng

Merck & Co., Inc.

Pei Huo

Merck & Co., Inc.

Geoffrey Walford

Merck & Co., Inc.

Mark D. Erion

Merck & Co., Inc.

David E. Kelley

Merck & Co., Inc.

Songnian Lin

Merck & Co., Inc.

James Mu

Merck & Co., Inc.